VENLAFAXINE HYDROCHLORIDE
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
71785-1006 -
Package NDC
71785-1006-0 -
Package NDC
71785-1006-1 -
Package NDC
71785-1006-2 -
Package NDC
71785-1006-3 -
Application number
ANDA212277 -
SPL ID
b45cbdea-d1be-c16d-e053-2a95a90a821e -
SPL set ID
e901e476-58bd-4204-baaa-a4634ae65ab3 -
UNII
7D7RX5A8MO -
RxCUI
313581 -
RxCUI
313583 -
RxCUI
313585
What the source publishes
- Labeler
- Annora Pharma Private Limited
- Active ingredients
- VENLAFAXINE HYDROCHLORIDE
- Form
- CAPSULE, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "VENLAFAXINE HYDROCHLORIDE",
"splId": "b45cbdea-d1be-c16d-e053-2a95a90a821e",
"labels": [
{
"setId": "e901e476-58bd-4204-baaa-a4634ae65ab3",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e901e476-58bd-4204-baaa-a4634ae65ab3",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=e901e476-58bd-4204-baaa-a4634ae65ab3"
}
],
"routes": [
"ORAL"
],
"labeler": "Annora Pharma Private Limited",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71785-1006-0)",
"package_ndc": "71785-1006-0",
"identifierStatus": "well-formed",
"marketing_start_date": "20190708"
},
{
"sample": false,
"description": "90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71785-1006-1)",
"package_ndc": "71785-1006-1",
"identifierStatus": "well-formed",
"marketing_start_date": "20190708"
},
{
"sample": false,
"description": "500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71785-1006-2)",
"package_ndc": "71785-1006-2",
"identifierStatus": "well-formed",
"marketing_start_date": "20190708"
},
{
"sample": false,
"description": "10 BLISTER PACK in 1 CARTON (71785-1006-3) / 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK",
"package_ndc": "71785-1006-3",
"identifierStatus": "well-formed",
"marketing_start_date": "20190708"
}
],
"productId": "71785-1006_b45cbdea-d1be-c16d-e053-2a95a90a821e",
"useDomain": "unknown",
"dosageForm": "CAPSULE, EXTENDED RELEASE",
"productNdc": "71785-1006",
"deaSchedule": null,
"genericName": "VENLAFAXINE HYDROCHLORIDE",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "VENLAFAXINE HYDROCHLORIDE",
"strength": "37.5 mg/1"
}
],
"applicationNumber": "ANDA212277",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20190708",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"7D7RX5A8MO"
],
"rxcui": [
"313581",
"313583",
"313585"
],
"spl_set_id": [
"e901e476-58bd-4204-baaa-a4634ae65ab3"
],
"manufacturer_name": [
"Annora Pharma Private Limited"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:71785-1006_b45cbdea-d1be-c16d-e053-2a95a90a821e"